$NVAX SEC Filings

Filed On	Filing
16 Oct 2026	SCHEDULE 13G
16 Oct 2026	SCHEDULE 13D/A
07 Aug 2026	SCHEDULE 13G
06 Aug 2026	FORM S-8
06 Aug 2026	8-K: Results of Operations and Financial Condition
06 Aug 2026	10-Q
23 Jun 2026	Form 4: Rodgers Richard J, Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units · Received 18,880 shares by exercise or conversion
23 Jun 2026	Form 4: King Rachel K., Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units · Received 18,880 shares by exercise or conversion
23 Jun 2026	Form 4: Douglas Richard, Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units · Received 18,880 shares by exercise or conversion
23 Jun 2026	Form 4: Mcglynn Margaret G, Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units · Received 18,880 shares by exercise or conversion
23 Jun 2026	Form 4: Mott David M, Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units · Received 18,880 shares by exercise or conversion
23 Jun 2026	Form 4: Alton Gregg H, Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units · Received 18,880 shares by exercise or conversion
23 Jun 2026	Form 4: Shiver John W., Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units
23 Jun 2026	Form 4: Newton Charles W., Director Granted 21,270 Stock Option (Right to Buy) · Granted 14,180 Restricted Stock Units
23 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
27 May 2026	144
15 May 2026	SCHEDULE 13D/A
07 May 2026	144
06 May 2026	10-Q
06 May 2026	8-K: Results of Operations and Financial Condition

Comments